Lataa...
Disposition of Posaconazole following Single-Dose Oral Administration in Healthy Subjects
Posaconazole is a potent, broad-spectrum triazole antifungal agent currently in clinical development for the treatment of refractory invasive fungal infections. Eight healthy male subjects received a single 399-mg (81.7 μCi) oral dose of [(14)C]posaconazole after consuming a high-fat breakfast. Urin...
Tallennettuna:
| Päätekijät: | , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Microbiology
2004
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC514780/ https://ncbi.nlm.nih.gov/pubmed/15328123 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.48.9.3543-3551.2004 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|